Trial Profile
Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Ropinirole (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 18 May 2008 Status changed from recruiting to completed.
- 14 Oct 2006 New trial record.